Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/25 16:08 | 4/16/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Barnett Eva Renee | NY | O | CFO | 2 | S | -103 | 17.78 | 0 | -6 | 397 | D | |||||||||||||||
4/17/25 16:07 | 4/16/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Salzmann Peter | NY | DO | CEO | 3 | S | -811 | 15.64 | 0 | -52 | 1,187 | D | |||||||||||||||
3/11/25 16:18 | 3/7/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Fromkin Andrew J. | NY | D | 1 | S | -157 | 19.60 | 0 | -8 | 92 | D | ||||||||||||||||
2/21/25 16:06 | 2/19/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Macias William L. | NY | O | Chief Me | 1 | S | -43 | 20.86 | 0 | -2 | 357 | D | |||||||||||||||
1/24/25 16:23 | 1/22/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NY | O | CTO | 1 | S | -52 | 23.59 | 0 | -2 | 140 | D | |||||||||||||||
1/24/25 16:22 | 1/22/25 | IMVT | Health | BioPrd | Biological Products, (No Diag | Geffner Michael | NY | O | Chief Me | 1 | S | -63 | 23.59 | 0 | -3 | 132 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |